M urine gammaherpesvirus 68 (␥HV68, also called MHV-68) 5 , a virus isolated originally from small rodents (1) , is a member of the ␥-herpesvirus subfamily, which includes EBV, the Kaposi's sarcoma-associated human herpesvirus 8 (HHV-8), and herpesvirus saimiri. The ␥HV68 sequence is more similar to HHV-8 (2, 3) , though the pathogenesis of ␥HV68 infection in the laboratory mouse has a number of biological and immunological features in common with human EBV infection. Little, if anything, is known about the acute phase of HHV-8 infection. The initial site of pathology in mice infected with ␥HV68 by the intranasal (i.n.) route is the lower respiratory tract where alveolar epithelial cells and mononuclear cells support virus replication (4) . Hematogenous spread of the virus results in low level, transient replication in distal sites, particularly the thymus and adrenal glands (4, 5) . Life-long latent infection of B lymphocytes (6) and macrophages (7) is established concurrently. Resolution of the pulmonary phase begins as infectious virus is cleared from the lung within 10 -12 days of challenge (4) . Prominent features of the host response are a transient, CD4
ϩ T cell-dependent splenomegaly peaking after approximately 2 wk (4, 8, 9) , and an infectious mononucleosis-like condition characterized by an increased frequency of activated CD8 ϩ T cells in the peripheral blood (10 -12) .
Control of acute ␥HV68 infection in the lung can be mediated by CD8 ϩ cytotoxic T cells (8) , and also CD4 ϩ effector T cells that function via secretion of IFN-␥ (13) . A slight delay in the clearance of virus from the lungs of Ig-deficient MT mice (14) indicates that virus-specific Ab makes only a minor contribution to this process. However, virus-specific Ig may be important in controlling the long-term, persistent phase of infection. This is suggested by experiments in which adult thymectomized mice were depleted of CD4 ϩ and CD8 ϩ T cells 1 mo after ␥HV68 infection. The mice retained high circulating levels of virus-specific IgG after depletion, and recrudescent pulmonary infection was not detected (15) . In contrast, elimination of the CD4 ϩ and/or CD8 ϩ T cell subsets in persistently infected MT mice resulted in the reemergence of infectious virus in the lungs and increased numbers of latently infected cells (13, 16) . A likely explanation is that Ab neutralization of free virus, and perhaps also Ab-dependent cellular cytotoxicity (17) , supplement CTL-mediated surveillance of latently infected cells.
Analysis of the Ab response to ␥HV68 infection has been limited to measurements of circulating Ig. Serum levels of virus-specific IgG and neutralizing activity increase sharply from days 10 -20 postinfection, and then continue to rise more gradually over several months (18, 19) . In addition, ␥HV68 infection induces a dramatic and sustained CD4 ϩ T cell-dependent increase in total serum IgG, indicating widespread, nonspecific B cell activation (18, 19) . The infection of B cells in vitro with ␥HV68 has a direct activating effect, resulting in proliferation and differentiation to IgM-producing cells. However, significant Ig class switching does not occur, even in the presence of CD4 ϩ T cells, indicating the importance of in vivo interactions that are not readily reproduced in cell culture (19) . The current study was undertaken to characterize the virus-specific and nonspecific Ab response to ␥HV68 at the single cell level. This defines for the first time the kinetics and isotype profile of the Ab response in different anatomical compartments during the acute and persistent phases of a ␥-herpesvirus infection. Some insights were also gained into the requirements and nature of the nonspecific component of the Ab response.
Materials and Methods

Viruses
Clone G2.4 of ␥HV68 was originally obtained from Dr. A. A. Nash (Edinburgh, U.K.), and virus stocks were grown in owl monkey kidney cells and titrated on NIH-3T3 cells (5) . Infectious ␥HV68 administered to mice was free of contamination with LPS (concentration Ͻ0.005 EU/ml) as determined by the Limulus amebocyte lysate assay (BioWhittaker, Walkersville, MD). Sendai virus administered i.n. (20) was used as a control agent in some experiments. Purified ␥HV68 for use in the immunoassays was prepared by differential centrifugation and sucrose banding of tissue culture grown virus. Influenza virus A/HKx31 (H3N2) for use as a control Ag was purified from stocks grown in the allantoic cavity of embryonated hen's eggs. Protein concentrations were determined by the method of Bradford (21) .
Mice
Wild-type (ϩ/ϩ) C57BL/6J (B6) and (B6 ϫ 129)F 2 mice, and mice deficient (Ϫ/Ϫ) for IL-6 (B6, 129-Il6) (22) , IFN-␥ (C57BL/6-Ifng) (23), or CD40 ligand (CD40L) (B6, 129-Cd40l) (24) were purchased from The Jackson Laboratory (Bar Harbor, ME). MHC class II (H-2 I-A b )-deficient B6C2D mice (C2D Ϫ/Ϫ ) (25) and B cell-deficient C57BL/6-Igh-6 mice (MT) (26) were bred at St. Jude Children's Research Hospital.
Radiation chimeras deficient in the expression of MHC class II molecules specifically on the B cell compartment were generated by i.v. injection of mixtures of C2D Ϫ/Ϫ and MT bone marrow (BM) cells into 8-to 10-wk-old B6 mice that had been lethally irradiated (950 rad) 1 day previously. Control chimeras with ϩ/ϩ B cells were made using a mixture of B6 and MT donor BM. Recipient mice were given Sulfatrim in their drinking water and held for at least 10 wk to allow full reconstitution before virus challenge. Chimeric mice were analyzed by flow cytometry (27) at the time of sampling to determine the prevalence and characteristics of various lymphocyte subsets. The staining reagents were FITC-conjugated mAbs to CD4 (RM4-4), I-A b (AF6-120.1), or CD44 (IM7), PEconjugated mAbs to CD4 (RM4-4), CD8␣ (53-6.7), or CD19 (1D3), and biotinylated mAbs to CD62L (MEL-14), all of which were purchased from PharMingen (San Diego, CA).
Mice were housed under specific pathogen-free conditions until ␥HV68 infection, and thereafter in BL3-level containment. Females were used in all studies and, with the exception of the BM chimeras, were infected at 8 -12 wk of age.
Infection and sampling
Mice were anesthetized with Avertin (2,2,2-tribromoethanol) given i.p., and then infected i.n. with 1 ϫ 10 4 PFU of ␥HV68 (in 30 l PBS). Anesthetized mice were exsanguinated via the retroorbital plexus before tissue sampling. Cervical lymph nodes (CLN, a pool of the superficial CLN and facial lymph nodes), the right posterior mediastinal lymph node (MLN), and spleen were collected and gently disrupted to generate single-cell suspensions in IMDM (Life Technologies, Grand Island, NY) supplemented with L-glutamine (2 mM), sodium pyruvate (1 mM), penicillin (100 IU/ml), streptomycin (100 g/ml), gentamicin (10 g/ml), and 15% FCS (complete medium). BM cell suspensions were obtained by flushing both femurs and tibiae. RBCs were removed from the spleen and BM preparations by ammonium chloride lysis.
The enzyme-linked immunosorbent spot-forming (ELISPOT) assay for Ab-forming cells
The ELISPOT assay (28) was adapted to enumerate ␥HV68-specific Abforming cells (AFC). Purified ␥HV68 was detergent-disrupted, diluted in PBS, and plated at 1 g/well in nitrocellulose-bottomed 96-well Multiscreen HA filtration plates (Millipore, Bedford, MA). After overnight incubation at 4°C, wells were washed with PBS and blocked with complete medium. Serial (5ϫ) dilutions of single cell suspensions were prepared in complete medium, and 100-l volumes were added to the plates beginning at 5 ϫ 10 5 cells/well. Plates were incubated for 3-4 h at 37°C in a humid atmosphere containing 5% CO 2 and then washed thoroughly. Alkaline phosphatase (ALP)-conjugated isotype-specific goat anti-mouse Abs (Southern Biotechnology Associates, Birmingham, AL) diluted 1/500 in PBS plus 5% BSA were added, and the plates were incubated overnight at 4°C. After extensive washing of both sides of the nitrocellulose filters, spots were developed at room temperature with 1 mg/ml of 5-bromo-4-chloro-3-indolyl phosphate (Sigma, St. Louis, MO) in diethanolamine buffer. Plates were washed and dried after optimal spot development. Blue spots representing individual AFC were counted using an Olympus SZH Stereozoom microscope. Negative control plates were coated with purified A/HKx31 (H3N2) influenza A virus. Total numbers of AFC were determined as described above except that plates were coated with goat antimouse light chain Abs (Southern Biotechnology Associates) diluted in PBS to give 0.5 g/well. Plates were similarly coated with goat anti-mouse light chain Abs (Southern Biotechnology Associates) to enumerate AFC secreting light chain Abs.
ELISA for virus-specific Ab
Nunc ImmunoMaxiSorp plates (Fisher Scientific, Pittsburgh, PA) were coated with purified, detergent-disrupted ␥HV68 diluted in PBS and plated at 0.25 g/well. After overnight incubation at 4°C, plates were washed with PBS-Tween (0.05%), blocked with PBS/BSA (3%), and washed again. Serum dilutions (3ϫ) starting at 1/100 (1/300 for IgM determinations) were prepared in PBS-Tween (0.05%)-BSA (0.5%) and added. The plates were incubated overnight at 4°C, then washed extensively, and bound Abs were detected with ALP-conjugated isotype-specific goat antimouse Abs (Southern Biotechnology Associates) diluted optimally in PBS-BSA (1%). After ϳ3 h incubation at room temperature, plates were washed thoroughly, and color was developed with p-nitrophenyl phosphate (Sigma) in diethanolamine buffer. Absorbance at 405 nm was read using a model 3550 microplate reader (Bio-Rad, Hercules, CA). The virus-specific serum Ab titer is expressed as the reciprocal of the highest dilution giving an absorbance value more than twice that for simultaneously titrated samples from naive mice.
Absorption with purified ␥HV68 was used to remove virus-specific Abs from serum (29) . Briefly, pooled sera from infected mice were diluted 1/50 or 1/100 in HBSS and incubated for 2.5 h at 4°C with 25 or 50 g of purified virus. Viral particles were pelleted by centrifugation, and Igs remaining in the supernatant were measured by ELISA.
ELISA for total serum Ig
Total serum levels of IgM, IgA, IgG1, IgG2a, IgG2b, and IgG3 were determined by a sandwich ELISA employing the washing, blocking, and incubation steps described above. Plates were coated with 5 g/ml goat anti-mouse Abs with specificity for IgM, IgA, IgG1, IgG2a, or IgG3 (Southern Biotechnology Associates), or with anti-mouse IgG2b mAb, clone R9-91 (PharMingen). Bound Ig was detected using ALP-goat antimouse IgM, IgA, IgG1, IgG2a, or IgG3 (Southern Biotechnology Associates), or ALP-anti-mouse IgG2b mAb, clone R12-3 (PharMingen) followed by p-nitrophenyl phosphate substrate. Concentrations were calculated from curves constructed using purified mouse Ig standards (Southern Biotechnology Associates). Serum levels of IgG and IgG were determined using goat anti-mouse or goat anti-mouse (Southern Biotechnology Associates) as capture Abs, ALP-goat anti-mouse IgG (Southern Biotechnology Associates) to detect specific binding, and mouse IgG2a (clone G155-178) or IgG2a (clone HOPC-1) mAb (PharMingen) as standards.
ELISA for anti-collagen Ab
Serum Abs to native murine type II collagen (CII) were measured by ELISA (30) . Briefly, sera were incubated in collagen-coated plates, and bound Abs were detected using peroxidase-conjugated goat anti-mouse IgG. The level of anti-CII IgG is reported as the absorbance of a 1/200 serum dilution. An inhibition assay was used to confirm the specificity of binding in the anti-CII ELISA. Briefly, serum was incubated with a range of concentrations of murine CII for 4 h at 4°C before being added to collagen-coated plates, and the ELISA was repeated as described above.
alkaline phosphatase-conjugated goat anti-mouse IgG. Titers are expressed as the reciprocal serum dilution that gave 50% of maximum binding determined by reference monoclonal IgM and IgG anti-DNA Abs.
Isoelectric focusing
Isoelectric focusing (IEF) of serum proteins (32) was performed in polyacrylamide Ampholine PAGplates, pH range 3.5-9.5 (Pharmacia Biotech, Piscataway, NJ) on a Multiphor II flatbed electrophoresis system (Pharmacia Biotech) set at 10°C. Electrode strips saturated with 1 M NaOH (catholyte) or 1 M H 3 PO 4 (anolyte) were applied to the gel, and 20-l aliquots of diluted sera were loaded on application strips positioned near the anode. Proteins focused for 90 min at 1500 V were transferred by capillary action to a methanol-treated and distilled water-moistened polyvinylidene difluoride (PVDF) Immobilon-P transfer membrane (Millipore). The membrane was carefully removed from the gel and sequentially treated with blocking buffer, biotinylated anti-mouse IgG2a b mAb, clone 5.7 (PharMingen), and HRP-conjugated streptavidin (Pierce, Rockford, IL). The blot was developed with the ECL Western blotting analysis system (Amersham, Arlington Heights, IL) and exposed to Biomax film (Sigma) to record the IgG2a spectrotype pattern.
Statistics
Statistical comparisons of mean values were performed using the nonparametric Mann-Whitney U test for unpaired samples.
Results
Kinetic analysis of the Ab response in B6 mice
The B cell ELISPOT assay was applied to analyze both the virusspecific and nonspecific AFC response in B6 mice infected i.n. with a sublethal ␥HV68 dose. At various times after infection, AFC responses were measured in the CLN and MLN, which receive lymphatic drainage from the upper and lower respiratory tract, respectively (33) , and in the spleen and BM. The CLN, MLN, and spleen participate in the early CD4 ϩ and CD8 ϩ T cell responses to ␥HV68 infection (18, 34, 35) and are, in addition, sites where latently infected B cell populations are first established (5) . The BM is recognized as a major site for the localization of long-lived AFC (36) and is considered to maintain high circulating levels of virus-specific Ab long after infectious virus has been cleared (37) (38) (39) . AFC responses in the CLN, MLN, spleen, and BM. The kinetics of the ␥HV68-specific and total AFC responses in the CLN, MLN, spleen, and BM are shown in Figs. 1 and 2 , respectively. The virus-specific response in the MLN slightly preceded responses in the CLN and spleen. In these sites, an early peak of virus-specific IgM AFC gave way to increased numbers of cells producing IgG isotypes, particularly IgG2a and IgG2b. Peak numbers of virusspecific AFC were attained in the CLN and MLN subsequent to 2 wk after infection, a somewhat delayed response compared with that associated with other respiratory viruses (38) . Generally, the numbers of virus-specific IgG AFC in the CLN, MLN, and spleen progressively decreased from 2 to 3 wk after virus infection. Surprisingly, essentially no virus-specific IgA AFC were generated in the CLN, a site where IgA generally contributes substantially to the response following respiratory infection with negative strand RNA viruses (20, 38) .
The virus-specific response in the CLN, MLN, and spleen was dwarfed by the increase in total AFC numbers (compare Figs. 1 and 2), measured as the number of lymphocytes producing Ig containing the light chain. Such lymphocytes represent ϳ90 -95% of AFC in normal mice (40) . The virus-specific assays applied in this study used purified, disrupted virions as target Ags. Responses to ␥HV68-encoded proteins that are not incorporated into the virion were therefore not detected. Nevertheless, the striking difference between total and specific AFC numbers (for instance, ϳ250-fold and 49-fold in the CLN and MLN, respectively, on day 10) indicates that the vast majority of AFC induced by ␥HV68 infection are not virus-specific. Total AFC numbers were maximal in the CLN and MLN from days 8 -12 postinfection and preceded the peak of the ␥HV68-specific response by approximately 5 days, suggesting that there may be subversion of the humoral response to the virus by extensive, nonspecific B cell activation. Interestingly, the isotype profiles of the virus-specific and total Ig responses were remarkably similar, and there was no increase in total IgA AFC numbers. Total AFC numbers in the CLN, MLN, and spleen decreased gradually after 2-3 wk.
The kinetics of the ␥HV68-specific AFC response in the BM was quite distinct from that in the CLN, MLN, and spleen, where responses clearly peaked and then declined. Virus-specific AFC appeared in the BM between 2 and 3 wk after infection, and numbers thereafter remained roughly constant, with IgG2a and IgG2b predominating. In addition, a significant increase in total IgG2a AFC in the BM ( p Ͻ 0.05 for day 15 and all subsequent sampling times compared with day 3) followed the same kinetics as the much smaller virus-specific AFC response in this location. Apparently, the nonspecific B cell activation associated with ␥HV68 infection generates a long-sustained population of BM AFC secreting non-virus-specific Ab. Serum Ab responses. Serum levels of virus-specific Ab (Figs. 3, A  and B) closely reflected the single cell analysis of the response. Specific IgM levels peaked early and subsided, whereas IgG subclass Ab titers increased rapidly from 1-3 wk after infection to a relatively stable plateau. The kinetic analysis of the AFC response ( Fig. 1) indicates that the elevated virus-specific serum Ab levels were maintained in the long-term by AFC in the BM, an observation consistent with studies of other virus systems (37) (38) (39) . No virus-specific serum IgA was detected during the acute response, reflecting the absence of significant numbers of specific IgA AFC in the respiratory lymph nodes and spleen. Infection with ␥HV68 induced increases in the total serum levels of a number of Ab isotypes (Fig. 3, C and D) , but most striking was a greater than 10-fold increase in the IgG2a concentration by day 10 after infection. Indeed, the increase in serum IgG2a primarily accounts for the previously reported ␥HV68-associated increase in serum IgG levels (18) . The proportion of serum IgG2a that was ␥HV68 specific was evaluated by absorbing sera from infected mice with purified virus. Treatment of pooled sera collected on day 10 after infection removed ϳ70% of the virus-specific IgG2a detected by ELISA. However, the total serum IgG2a concentration was unaffected, indicating that most of the Ig produced in the course of infection is not specific for the virus. Substantially elevated serum IgG2a levels were maintained for the duration of sampling, apparently due in large part to the non-virus-specific AFC population that was established in the BM (Fig. 2) .
Nonspecific Ab production in cytokine-deficient mice
The production of non-virus-specific Ab in vivo following ␥HV68 infection is dependent on CD4 ϩ T cells (19) and may be driven by cytokines, perhaps acting in concert with virus infection of B cells. Previous studies of other virus systems have identified IL-6 and IFN-␥ as factors contributing to the magnitude of the nonspecific Ab response (41, 42) , and high levels of these cytokines are generated in vivo by ␥HV68 (43). IL-6 is well recognized as a factor acting on B cells to induce Ig secretion (44) , and the production of IL-6 by B cells infected in vitro with ␥HV68 (43) suggests a role for the cytokine as a virus-induced autocrine growth factor. IFN-␥ induces Ig production by activated B cells (45) and is also the major cytokine promoting class switching to IgG2a (46) . These functions suggest a significant role for IFN-␥ in the vigorous, IgG2a-biased, nonspecific Ab response associated with ␥HV68 infection.
Total AFC frequencies were determined in the respiratory lymph nodes of IL-6
, and appropriate ϩ/ϩ control mice at the peak of the response, and serum IgG1, IgG2a, and IgG2b concentrations at this time were compared with preinfection levels. Neither the isotype profile nor the magnitude of the AFC response (Fig. 4 , A-C) were obviously modified in the IL-6 Ϫ/Ϫ mice. Total serum IgG2a and IgG2b levels, but not IgG1 levels, were significantly increased ( p Ͻ 0.05) in IL-6 Ϫ/Ϫ and IL-6 ϩ/ϩ mice (data not shown). Apparently, IL-6 is not required to drive the nonspecific Ig response. The absence of IFN-␥ had a much more profound effect, resulting in significantly increased frequencies ( p Ͻ 0.05) of IgA, IgG1, and IgG2b AFC in both the CLN and MLN (Fig. 4 , D and E) and total AFC in the MLN (Fig. 4F) . Serum IgG2a and IgG2b levels were significantly increased ( p Ͻ 0.05) in both IFN-␥ Ϫ/Ϫ and IFN-␥ ϩ/ϩ mice, with the rise in IgG2b being particularly marked in the IFN-␥ Ϫ/Ϫ mice. In addition, the serum IgG1 level was significantly increased ( p Ͻ 0.05) in the IFN-␥ Ϫ/Ϫ mice, but not in the IFN-␥ ϩ/ϩ mice (data not shown). The increase in the nonspecific B cell response in the IFN-␥ Ϫ/Ϫ mice could be thought to reflect that this cytokine is inhibitory, though it is also the case that the lytic phase of infection is controlled less rapidly in the absence of IFN-␥ (13, 34), so the magnitude of the antigenic stimulus will be greater.
Nonspecific Ab production requires cognate T-B interactions
The CD4
ϩ T cell dependence of non-virus-specific Ab production following ␥HV68 infection in vivo (19) indicates a requirement for T cell-derived factors and/or cognate CD4 ϩ T cell help to drive B cell activation. A key molecular interaction in T-B collaboration is the binding between CD40L, which is expressed on activated CD4 ϩ T cells, and CD40 on B cells (47) . The contribution of CD40-CD40L signaling to nonspecific Ab production induced by ␥HV68 was assessed in experiments comparing CD40L Ϫ/Ϫ and CD40L ϩ/ϩ mice. Determination of total AFC frequencies at the peak of the response in the respiratory lymph nodes demonstrated absent or relatively weak responses in CD40L Ϫ/Ϫ mice, in contrast to vigorous responses in CD40L ϩ/ϩ mice (Fig. 5, A and B) . In a second experiment using a lower virus dose (600 PFU) and sampling the CLN and MLN on days 7, 15, and 35 postinfection, a strong, nonspecific AFC response developed in ϩ/ϩ mice, whereas total AFC numbers did not increase in CD40L
Ϫ/Ϫ mice (data not shown).
Although our results clearly demonstrate that non-virus-specific Ab production following ␥HV68 infection is dependent on CD40-CD40L interactions, this could be attributed to greatly reduced activation of CD4 ϩ T cells in CD40L Ϫ/Ϫ mice (12, 48) and not necessarily to the contribution of CD40-CD40L binding for cognate T-B help. Radiation BM chimeras were therefore generated to provide a system in which complete CD4 ϩ T cell activation can occur, but specific, contact-dependent CD4 ϩ T cell help to drive B cell responses is prevented by the absence of MHC class II expression on B cells. Normally, cognate CD4 ϩ T cell help for thymus-dependent humoral responses is initiated by engagement of the TCR with the Ag-MHC class II complex on the B cell. Chimeric mice with MHC class II-deficient B cells were constructed by reconstituting irradiated recipient B6 mice with donor BM from C2D Ϫ/Ϫ (MHC class II-deficient) mice and MT (B cell-deficient) mice. BM elements from MT mice will generate the MHC class II-expressing APC required to stimulate CD4 ϩ T helper cells. Control ϩ/ϩ chimeric mice were produced as above, but with B6 BM substituted for C2D Ϫ/Ϫ BM. The two sets of chimeras were infected with ␥HV68, and total AFC numbers were determined at the peak of the response in the respiratory lymph nodes. Total AFC frequencies remained at low levels in mice with MHC class II Ϫ/Ϫ B cells, whereas a vigorous response developed in the control animals (Fig. 5, C and D) . The cellularity of the lymph nodes at the time of sampling was similar in the two sets of chimeras, as were the proportions of B cells (CD19 ϩ ) and CD4 ϩ and CD8 (49) . Thus, even in the face of apparently complete CD4 ϩ T cell activation, ␥HV68-induced nonspecific B cell activation and Ab production remained dependent on cognate help, perhaps as a prerequisite for the participation of activated B cells in normal germinal center processes. An implication is that the activated T cells are recognizing some antigenic change on substantial numbers of B cells that are not specific for viral components.
Nonspecific Ab production reflects polyclonal B cell activation
Vigorous, non-virus-specific Ab production following ␥HV68 infection is strongly suggestive of polyclonal B cell activation, a feature of infection with a number of herpesviruses (41, 50, 51) . The clonality of the nonspecific response to ␥HV68 was evaluated using isoelectric focusing to generate spectrotype profiles of serum IgG2a Abs, since this isotype dominated the nonspecific response. Spectrotyping of sera collected on day 10 after infection established that the IgG2a increase elicited by ␥HV68 represented a very diverse molecular population (Fig. 6) , indicating polyclonal B cell activation. Indeed, virus infection amplified at least as many bands as could be identified by spectrotyping IgG2a in sera pooled from 10 uninfected mice. Absorption of the day 10 sera with purified virus removed 70% of the virus-specific IgG2a detected by ELISA, but had no effect on the spectrotype, indicating that the bands reflect nonspecific Ab production.
Also, though infection with ␥HV68 generated an ϳ10-fold increase in total serum IgG2a levels within 2-3 wk, the ratio of -to -containing IgG molecules remained constant during this period (data not shown), a result consistent with extensive, nonselective B cell activation.
Autoantibody induction by ␥HV68
There is evidence that polyclonal B cell activation results in the production of Abs directed against self components and may lead to the development of systemic autoimmune disease (52) . Sera collected at different times following ␥HV68 infection were thus tested for IgG Abs reactive with mammalian dsDNA and murine CII. Comparisons were made with sera from mice infected with Sendai virus, a negative strand RNA virus that activates B cells nonspecifically (29, 53) . Infection with Sendai virus, like ␥HV68, induced a substantial and sustained increase in total serum IgG2a and IgG2b concentrations, although the maximum IgG2a levels were ϳ1.5ϫ higher following exposure to ␥HV68 (data not shown). Significant levels of anti-dsDNA and anti-CII Abs were present in more than 50% of mice from day 21 after ␥HV68 infection and remained high in some mice for at least 12 wk (Fig. 7,  A and B) . The specificity of the anti-CII Abs was demonstrated in an inhibition assay in which the preincubation of serum with CII completely abolished high binding in the anti-CII ELISA. No significant anti-dsDNA or anti-CII binding was detected in sera from mice infected with Sendai virus. Total serum Ig levels were relatively constant in ␥HV68-infected mice from day 21 after challenge (Fig. 3D) , indicating that the greater reactivity to dsDNA and mCII in only a proportion of the mice cannot be attributed to a general increase in assay background. This is also indicated by the absence of any correlation between high levels of binding on plates coated with distinct Ags (dsDNA, CII, or the conventional Ag OVA). The induction by ␥HV68 of IgG Abs reactive with two distinct self Ags further supports the polyclonal nature of B cell activation caused by the virus, and raises the possibility that ␥-herpesvirus infections may trigger autoimmune disease.
Discussion
The B cell ELISPOT assay has previously been applied in a number of models of virus infection to characterize the production of virus-specific Ab at the single cell level (38, 39, 54, 55) . However, the current analysis of Ab production following ␥HV68 infection takes into account both the generation of virus-specific AFC, and the nonspecific B cell activation that is a feature of many virus infections (29) and may be particularly relevant to the pathogenesis of the B lymphotropic ␥-herpesviruses. The specific response to ␥HV68 had features in common with the response to other respiratory viruses, namely, the kinetics of Ab production in different anatomical compartments (38) , and the general predominance of the IgG2a and IgG2b isotypes (38, 56) . There was no indication that the response was modified by potentially continuous antigenic stimulation that may result from reactivation of ␥HV68 from sites of latency in the lung (14, 16) and lymphoid tissue (5) . The ␥HV68-specific AFC response in the respiratory lymph nodes was somewhat delayed and of a smaller magnitude compared with responses in the same locations following infection with influenza or Sendai virus (20, 38) . Although this may reflect differences in the Ag load, a significant factor may be the B cell tropism of ␥HV68 and the resultant loss of B cells by lytic infection (4), apoptosis (19) , or CD8 ϩ T cell-mediated clearance (8) . The peak ␥HV68-specific AFC response in the CLN, MLN, and spleen was slightly preceded by a dramatic increase in nonspecific AFC numbers, suggesting that virus-driven, nonspecific B cell activation may also contribute to a dampening of the specific humoral response. However, numerous viruses including influenza and Sendai have the capacity to activate B cells nonspecifically (29, 57) , and factors such as the mechanism and extent of this process may well determine the effect, if any, on virus-specific Ab production.
A surprising feature of the Ab response to ␥HV68, in marked contrast to the response to other respiratory viruses (20, 28, 38) , was the almost complete absence of ␥HV68-specific IgA AFC in the CLN and MLN. The CLN in particular is recognized as a site biased toward the production of IgA (58), and virus-specific IgA AFC characteristically constitute a significant proportion of the response in the CLN following i.n. immunizations with live or inactivated virus (20) . The processes by which IgA responses are generated in the respiratory tract are not well understood, but there is evidence (59) that B cells in close association with the respiratory epithelium (60) are particularly important. Conceivably, lytic infection of these cells at an early stage of ␥HV68 infection may subvert the induction of specific IgA AFC. The response to ␥HV68 in the CLN follows approximately the same kinetics as that in the MLN and is well developed before any response is apparent in nonrespiratory lymph nodes such as the axillary and brachial (data not shown). This indicates that ␥HV68 accesses the CLN from the respiratory tract. The possibility that the virus replicates in epithelial cells in the nasopharynx or other regions of the upper respiratory tract that would be expected to drain to the CLN (60) has not been analyzed. A possible scenario is that ␥HV68 spreads to the CLN via B cells that are directly infected in the upper respiratory tract. There is recent evidence (61) that EBV enters the human host by B cell infection alone (62) .
The ␥HV68-specific response in the CLN, MLN, and spleen was accompanied by a dramatic increase in the number of nonvirus-specific AFC (Figs. 1 and 2 ). Both the virus-specific and nonspecific responses displayed similar kinetics and isotype profiles, consistent with speculation (19) that the nonspecific response (like the specific response) requires the participation of activated B cells in normal germinal center processes. Surprisingly, ␥HV68 infection induced a substantial and long-sustained increase in nonspecific AFC numbers in the BM. These cells presumably maintain the elevated levels of circulating, non-virus-specific Ig. To date, the BM as a long-term reservoir of AFC has been described only in the context of specific responses to viral infection (37) (38) (39) or immunizations with inert, thymus-dependent Ags (63) (64) (65) . The observation that ␥HV68 infection generates increased numbers of non-virus-specific AFC in the BM is further evidence that these cells originate in germinal center reactions, since BM AFC appear to be derived from cells that emerge from germinal centers (65, 66) . It will be of interest to determine whether long-lasting, nonspecific AFC populations in the BM also result from infection with the many other viruses that are able to nonspecifically activate B cells (29, 57) . These viruses represent a broad range of taxonomic groups, and the process of nonspecific B cell activation is therefore unlikely to have a uniform mechanistic basis.
Experiments were conducted to define more precisely the requirements for the CD4 ϩ T cell-dependent production of non-virus-specific Ab following ␥HV68 infection (19) . Analysis of cytokine-deficient mice (Fig. 4) demonstrated that the nonspecific Ab response is not dependent on IL-6 or IFN-␥. However, nonspecific Ab production induced by ␥HV68 was substantially diminished in CD40L Ϫ/Ϫ mice and in chimeric mice lacking MHC class II expression specifically on B cells (Fig. 5) . Engagement of the TCR with MHC class II-peptide on B cells cannot take place in the chimeric mice, with consequent disruption of a series of downstream events that normally lead to the participation of B cells in germinal center reactions and the production of thymus-dependent Ab (67) . Perhaps pivotal in this process is up-regulation of the transiently expressed CD40L on helper T cells that results from FIGURE 7. Induction of autoantibodies by ␥HV68. B6 mice were infected i.n. with ␥HV68 or Sendai virus. Sera collected at intervals after infection were analyzed by ELISA for IgG Abs to mammalian dsDNA (A) or murine type II collagen (B). Anti-dsDNA titers were determined by endpoint titration and are expressed as the reciprocal of the serum dilution. Anti-collagen levels are shown as the absorbance of a 1/200 serum dilution. Cut-off values for significance are arbitrarily set at 100 and 0.2 for antidsDNA and anti-collagen levels, respectively. Each point represents the result for an individual mouse.
signaling through the TCR (47) . Our results indicate a requirement for cognate CD4 ϩ T cell help to drive the nonspecific B cell activation associated with ␥HV68 infection, with CD40-CD40L interaction as an essential signaling component. Signaling to B cells through CD40 is a prerequisite for normal germinal center processes (68) , and it follows that the production of non-␥HV68-specific Ab may depend on the germinal center for B cell proliferation and differentiation. A key question concerns the nature of the CD4 ϩ T cell help that drives the process, which may well be the normal, Ag-specific CD4 ϩ T cell response. Conceivably, a virusencoded molecule may mediate a non-Ag-specific interaction between MHC class II on the surface of infected B cells and the appropriate TCR on CD4 ϩ T cells (69). Our observations indicate that the production of nonspecific Abs that is such a prominent feature of ␥HV68 infection is a consequence of generalized polyclonal B cell activation. In this regard, ␥HV68 is similar to a number of other herpesviruses including the human pathogens EBV (50, 70) and CMV (51) . Both EBV and CMV also induce Abs that bind to host Ags (71, 72) , a consequence that may relate to the activity of these viruses as polyclonal B cell activators (52) . Herpesvirus-induced polyclonal B cell activation and autoantibody production have been most thoroughly studied in mice infected with murine CMV (MCMV). Although some antigenic cross-reactivity between host and MCMV proteins has been described (73, 74) , the production of multiple autoantibodies of different specificities during MCMV infection (75) suggests that generalized polyclonal B cell activation (41, 76) is largely responsible. Autoantibody production in ␥HV68-infected mice may also derive from nonselective, polyclonal B cell activation. However, isotype-switched Abs reactive with mammalian dsDNA and murine CII were generated in only a proportion of mice infected with ␥HV68 (Fig. 7, A and B) , suggesting the involvement of some stochastic processes. This feature may indicate a role for Ag-driven selection in the production of some autoantibodies, particularly anti-DNA. There is evidence (77) that Abs specific for host dsDNA, and non-cross-reactive with viral dsDNA, may be selectively induced by the binding of virus-encoded proteins to cellular DNA. Serum levels of anti-dsDNA and anti-CII Abs remained high in some ␥HV68-infected mice for the duration of sampling, raising the possibility of autoantibody-mediated pathology, though a role for the virus in the induction of autoimmune disease in the laboratory mouse has not otherwise been investigated. It will be of interest to determine whether the potentially long-lived (36), non-virus-specific AFC in the BM generated by ␥HV68 infection include autoantibody-secreting cells.
